Kolexia
Zawadi Ayman Radio-thérapie
Zawadi Ayman
Radio-thérapie
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
28 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du côlon Tumeurs colorectales Adénocarcinome Carcinomes Instabilité des microsatellites Tumeurs du cerveau Tumeurs du rectum Syndromes néoplasiques héréditaires Tumeurs de la prostate

Collaborateurs

Voir plus
Taieb Julien
Taieb Julien
Hôpital Européen Georges Pompidou, Paris, France
Morand Clotilde
Morand Clotilde
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
Laurent-Puig Pierre
Laurent-Puig Pierre
Hôpital Européen Georges Pompidou, Paris, France
Deniaud-Alexandre Elisabeth
Deniaud-Alexandre Elisabeth
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France

Industries

Voir plus
BMS
2 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2019
Merck-Serono
1 collaboration(s)
Dernière en 2019
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer
Essai Clinique (National Cancer Institute)   28 avril 2020
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.
JCO precision oncology   26 février 2020
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
JAMA oncology   11 septembre 2019
2007/02: A Phase III Randomized Multicenter Study,Comparing an Induction Chemotherapy Followed by Irradiation and Concurrent Erbitux Versus Chemoradiotherapy for Patients With Locoregional Advanced Head and Neck Cancers
Essai Clinique (Groupe d'Oncologie Radiothérapie Tête Et Cou)   17 janvier 2019
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 juillet 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 juin 2018
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Annals of oncology : official journal of the European Society for Medical Oncology   25 juin 2015
O-021 Analysis of DNA mismatch repair and clinical outcome in stage III colon cancers from patients treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials
ESMO 17th World Congress on Gastrointestinal Cancer, 1-4 July 2015, Barcelona, Spain   01 juin 2015
Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.
Annals of oncology : official journal of the European Society for Medical Oncology   03 mars 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Annals of oncology : official journal of the European Society for Medical Oncology   06 octobre 2014